DN
Dubois-Stringfellow Nathalie
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Dubois-Stringfellow Nathalie. Director active across 1 company, notably Sangamo Therapeutics, INC. Aggregated, 21 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €76k. Activity tracked since 24 February 2023. The latest transaction was filed on 25 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Dubois-Stringfellow Nathalie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
4,036 shares@ US$0.17430.0004% mcap0.3% of flowCommon StockSEC:0001947007-26-000012:0
345,942 shares@ US$0.25780.28% mcap29.4% of flowCommon StockSEC:0001947007-26-000010:0
2,063 shares@ US$0.47250.3% of flowCommon StockSEC:0001947007-26-000004:0
36,676 shares@ US$0.39854.0% of flowCommon StockSEC:0001947007-26-000002:0
2,544 shares@ US$0.41660.3% of flowCommon StockSEC:0001947007-25-000006:0
43,741 shares@ US$0.668.4% of flowCommon StockSEC:0001947007-25-000004:0
1,792 shares@ US$0.58630.3% of flowCommon StockSEC:0001415889-25-023071:0
31,866 shares@ US$0.47984.8% of flowCommon StockSEC:0001415889-25-020243:0
1,792 shares@ US$0.47330.2% of flowCommon StockSEC:0001415889-25-014694:0
31,866 shares@ US$0.776312.0% of flowCommon StockSEC:0001415889-25-011281:0
1,792 shares@ US$1.000.9% of flowCommon StockSEC:0001415889-25-005707:0
129,593 shares@ US$1.1578.7% of flowCommon StockSEC:0001415889-25-002020:0
1,787 shares@ US$1.881.8% of flowCommon StockSEC:0001415889-24-027704:0
1,787 shares@ US$0.860.8% of flowCommon StockSEC:0001415889-24-022307:0
1,787 shares@ US$0.600.5% of flowCommon StockSEC:0001415889-24-014798:0
5,474 shares@ US$1.133.1% of flowCommon StockSEC:0001415889-24-005549:0
712,500 shares0Common StockSEC:0001415889-24-001755:0
1,462 shares@ US$0.38210.3% of flowCommon StockSEC:0001209191-23-056777:0
1,462 shares@ US$0.770.6% of flowCommon StockSEC:0001209191-23-047579:0
1,462 shares@ US$1.331.0% of flowCommon StockSEC:0001209191-23-032909:0
53,438 shares0Common StockSEC:0001209191-23-016393:0
About Dubois-Stringfellow Nathalie
Dubois-Stringfellow Nathalie is a declarant linked to Sangamo Therapeutics, INC, where the listed role is SVP-CHIEF DEVELOPMENT OFFICER. She has 21 filings in total, and across the sampled recent filings, sales amount to EUR 75938, with a date range from 2023-03-06 to 2026-05-27; the most common transaction nature is Retenue fiscale.